SCHEMBL5500407

SCHEMBL5500407

O=C(O)NC1CCN(c2nc(-c3ccccc3O)nc3ccc(F)cc23)C1I

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 9/20 0.42
SMAD3 P84022 1/20 0.41
CASR P41180 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CHEK1 O14757 4/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSP90AA1 P07900 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1624929 0.87 CHEK2 (0.42) CHEK2SMAD3CASRMEN1KMT2A
SCHEMBL5506146 0.85 KMT2A (0.43) CHEK2SMAD3MEN1KMT2ACHEK1
SCHEMBL5504628 0.85 CHEK2 (0.40) CHEK2SMAD3CASRMEN1KMT2A
SCHEMBL1622823 0.84 CHEK2 (0.38) CHEK2SMAD3CASRMEN1KMT2A
Hydrochloric Acid SCHEMBL1624765 0.83 CHEK2 (0.38) CHEK2SMAD3CASRMEN1KMT2A
SCHEMBL1622775 0.81 MAPT (0.45) CHEK2SMAD3CASRMEN1KMT2A
SCHEMBL5505194 0.80 SMAD3 (0.44) CHEK2SMAD3MEN1KMT2ACHEK1
SCHEMBL183513 0.80 CHEK2 (0.54) CHEK2SMAD3CASRMEN1KMT2A
SCHEMBL1622030 0.80 CHEK2 (0.54) CHEK2SMAD3CASRMEN1KMT2A
Hydrochloric Acid SCHEMBL4013873 0.79 CHEK2 (0.53) CHEK2SMAD3MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784393-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2007-05-16 EP disclosed
WO-2006028904-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-03-16 WO disclosed